Ablynx

@AblynxABLX

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® for a range of serious human diseases.

Ghent/Zwijnaarde, Belgium
ablynx.com
Iscritto a maggio 2012
5 foto e video Foto e video

Tweet

Hai bloccato @AblynxABLX

Sei sicuro di voler vedere questi Tweet? Visualizzare i Tweet non sbloccherà @AblynxABLX

  1. ha ritwittato
    26 lug

    FDA designates top nanobody caplacizumab fast track designation: 6-10 months faster approval

    3 Retweet 4 Mi piace
  2. ha ritwittato
    20 lug

    2.4bn "bioeuro": Belgian Nanobody delights now also tasteful in France

    2 Retweet 7 Mi piace
  3. 20 lug

    and Sanofi to develop up to 8 Nanobody®-based therapeutics focused on immuno-inflammatory diseases

    1 risposta 9 Retweet 14 Mi piace
  4. 27 giu

    achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc.

    7 Retweet 16 Mi piace
  5. 26 giu

    initiates a single and multiple dose Phase I study of caplacizumab in healthy Japanese subjects

    4 Retweet 6 Mi piace
  6. 29 mag

    launches , a new website dedicated to Thrombotic Thrombocytopenic Purpura (TTP)

    10 Retweet 9 Mi piace
  7. 22 mag

    receives €15M milestone from Merck KGaA for novel Nanobody in osteoarthritis

    10 Retweet 12 Mi piace
  8. 18 mag

    Meet our experts and recruiters (booth 99) @

    2 Mi piace
  9. 11 mag

    Ablynx zit op schema via

    4 Retweet 6 Mi piace
  10. 11 mag

    Q1 2017 "Positive start of the year; good progress in multiple programmes; strong cash position"

    6 Retweet 4 Mi piace
  11. 10 mag

    Publication in Journal of Thrombosis and Haemostasis "Caplacizumab reduces major thromboembolic events"

    7 Retweet 7 Mi piace
  12. 2 mag

    successfully completes patient recruitment in its Phase III Hercules study of caplacizumab

    2 Retweet 6 Mi piace
  13. 7 apr

    Annual Report 2016 is available online - view via

    1 Retweet 4 Mi piace
  14. 7 apr

    - Adrianus van Herk (aandeelhouder Ablynx): 'België en Nederland zijn wereldtop' via @trends

    1 Retweet 4 Mi piace
  15. ha ritwittato
    6 mar

    Compelling data for developed psoriasis nanobody in collaboration

    3 Retweet 2 Mi piace
  16. ha ritwittato
    28 feb

    Good morning to those waking up in Europe, Africa and the Middle East! Share with us what you have planned for today!

    15 risposte 51 Retweet 103 Mi piace
  17. ha ritwittato
    24 feb

    you will find out that is dedicated to creating new medicines which will make a real difference to society!

    1 Retweet 1 Mi piace
  18. 23 feb

    FYR 2016: significant progress in R&D pipeline; strong cash position; major catalysts in 2017.

    4 Retweet 3 Mi piace
  19. 9 feb

    will present additional data from the Phase IIb RA combination study of vobarilizumab at the Annual CRA Meeting

    2 Retweet 2 Mi piace
  20. 6 feb

    Ablynx files caplacizumab for ultra rare blood disorder
    6 Retweet 9 Mi piace

@AblynxABLX non ha ancora twittato.

Il caricamento sembra essere lento.

Twitter potrebbe essere sovraccarico o avere un problema temporaneo. Riprova o visita Twitter Status per ulteriori informazioni.

    Potrebbero piacerti

    ·